Sonoma Pharmaceuticals, Inc. (SNOA)
NCM – Real Time Price. Currency in USD
1.34
-0.03 (-2.19%)
Market open: Aug 12, 2026, 12:28 PM EDT
1.38
+0.01 (0.73%)
Previous after-hours: Aug 11, 2026, 7:41 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
1.34
-0.03 (-2.19%)
Market open: Aug 12, 2026, 12:28 PM EDT
1.38
+0.01 (0.73%)
Previous after-hours: Aug 11, 2026, 7:41 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $5.3M significantly exceed its total debt $739.0K, ensuring strong financial flexibility
Total current assets $16.3M exceed Total current liabilities $5.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (-0.8), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$651.0K limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.99 | 2.52 | 10 | |
| Quick ratio | 2.29 | 1.78 | 10 | |
| Debt to Equity | 0.11 | -0.80 | 9.0 | |
| Debt to Assets | 0.04 | 0.73 | 9.0 | |
| Interest coverage | N/A | -13.90 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 13M | 13M | 14M | 20M | 22M |
| Gross Profit | 4M | 5M | 5M | 7M | 9M |
| Operating Income | -5M | -5M | -4M | -2M | -1M |
| Net Income | -5M | -5M | -3M | -3M | -2M |
| EBITDA | -4M | -5M | -4M | -2M | -1M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -5.6 | 68.75 | 5.5 |
| Next quarter | 24.4 | 81.25 | 10 |
| Current year | 22.44 | 70.37 | 10 |
| Next year | 12.73 | 112.5 | 9.0 |
| Weighted average score | 8.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 15.2 | 43.2 | 104.56 | -18.79 | 7.5 |
| Y/Y | 59.55 | 73.41 | 101.98 | 69.31 | 10 |
| 3y average | 14.94 | 14.26 | 50.51 | -733.3 | 6.8 |
| 5y average | 3.55 | 6.76 | 50.51 | -453.91 | 5.0 |
| Weighted average score | 7.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |